Skip to Content
Merck

Mucosal immunity and vaccines.

Nature medicine (2005-04-07)
Jan Holmgren, Cecil Czerkinsky
ABSTRACT

There is currently great interest in developing mucosal vaccines against a variety of microbial pathogens. Mucosally induced tolerance also seems to be a promising form of immunomodulation for treating certain autoimmune diseases and allergies. Here we review the properties of the mucosal immune system and discuss advances in the development of mucosal vaccines for protection against infections and for treatment of various inflammatory disorders.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
IgA, Kappa from murine myeloma, clone TEPC 15, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
IgA from human colostrum, reagent grade, ≥95%, essentially salt-free, lyophilized powder
Sigma-Aldrich
IgA from human colostrum, reagent grade, buffered aqueous solution